On the one hand, tumour-associated antigens, such as human epidermal growth factor receptor 2 (HER2) or mesothelin, are often also expressed in healthy tissues, leading to on-target off-tumour toxicities8–10. This evidence concerns the gene ERBB2 and neoplasm.